Top

Published in:

Open Access 01-12-2007 | Research article

CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in northern Sweden

Authors: Sofia Mayans, Kurt Lackovic, Caroline Nyholm, Petter Lindgren, Karin Ruikka, Mats Eliasson, Corrado M Cilio, Dan Holmberg

Published in: BMC Medical Genetics | Issue 1/2007

Abstract

Background

Polymorphisms in and around the CTLA-4 gene have previously been associated to T1D and AITD in several populations. One such single nucleotide polymorphism (SNP), CT60, has been reported to affect the expression level ratio of the soluble (sCTLA-4) to full length CTLA-4 (flCTLA-4) isoforms. The aims of our study were to replicate the association previously published by Ueda et al. of polymorphisms in the CTLA-4 region to T1D and AITD and to determine whether the CT60 polymorphism affects the expression level ratio of sCTLA-4/flCTLA-4 in our population.

Methods

Three SNPs were genotyped in 253 cases (104 AITD cases and 149 T1D cases) and 865 ethnically matched controls. Blood from 23 healthy individuals was used to quantify mRNA expression of CTLA-4 isoforms in CD4⁺ cells using real-time PCR. Serum from 102 cases and 59 healthy individuals was used to determine the level of sCTLA-4 protein.

Results

Here we show association of the MH30, CT60 and JO31 polymorphisms to T1D and AITD in northern Sweden. We also observed a higher frequency of the CT60 disease susceptible allele in our controls compared to the British, Italian and Dutch populations, which might contribute to the high frequency of T1D in Sweden. In contrast to previously published findings, however, we were unable to find differences in the sCTLA-4/flCTLA-4 expression ratio based on the CT60 genotype in 23 healthy volunteers, also from northern Sweden. Analysis of sCTLA-4 protein levels in serum showed no correlation between sCTLA-4 protein levels and disease status or CT60 genotype.

Conclusion

Association was found between T1D/AITD and all three polymorphisms investigated. However, in contrast to previous investigations, sCTLA-4 RNA and protein expression levels did not differ based on CT60 genotype. Our results do not rule out the CT60 SNP as an important polymorphism in the development of T1D or AITD, but suggest that further investigations are necessary to elucidate the effect of the CTLA-4 region on the development of T1D and AITD.

Available only for authorised users

Levin L, Tomer Y: The etiology of autoimmune diabetes and thyroiditis: evidence for common genetic susceptibility. Autoimmun Rev. 2003, 2: 377-386. 10.1016/S1568-9972(03)00080-6.CrossRefPubMed

Kordonouri O, Klinghammer A, Lang EB, Gruters-Kieslich A, Grabert M, Holl RW: Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter survey. Diabetes Care. 2002, 25: 1346-1350.CrossRefPubMed

Barker JM: Type 1 diabetes associated autoimmunity: Natural History, Genetic Associations and Screening. J Clin Endocrinol Metab. 2006

Jenkins RC, Weetman AP: Disease associations with autoimmune thyroid disease. Thyroid. 2002, 12: 977-988. 10.1089/105072502320908312.CrossRefPubMed

Einarsdottir E, Soderstrom I, Lofgren-Burstrom A, Haraldsson S, Nilsson-Ardnor S, Penha-Goncalves C, Lind L, Holmgren G, Holmberg M, Asplund K, Holmberg D: The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease. Eur J Hum Genet. 2003, 11: 81-84. 10.1038/sj.ejhg.5200903.CrossRefPubMed

Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Larrad MT, Rios MS, Chow CC, Cockram CS, Jacobs K, Mijovic C, Bain SC, Barnett AH, Vandewalle CL, Schuit F, Gorus FK, Tosi R, Pozzilli P, Todd JA: The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet. 1996, 5: 1075-1080. 10.1093/hmg/5.7.1075.CrossRefPubMed

Turpeinen H, Laine AP, Hermann R, Simell O, Veijola R, Knip M, Ilonen J: A linkage analysis of the CTLA4 gene region in Finnish patients with type 1 diabetes. Eur J Immunogenet. 2003, 30: 289-293. 10.1046/j.1365-2370.2003.00407.x.CrossRefPubMed

Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC: Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 2003, 423: 506-511. 10.1038/nature01621.CrossRefPubMed

Magistrelli G, Jeannin P, Herbault N, Benoit De Coignac A, Gauchat JF, Bonnefoy JY, Delneste Y: A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. Eur J Immunol. 1999, 29: 3596-3602. 10.1002/(SICI)1521-4141(199911)29:11<3596::AID-IMMU3596>3.0.CO;2-Y.CrossRefPubMed

10.

Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25: 402-408. 10.1006/meth.2001.1262.CrossRefPubMed

11.

Oaks MK, Hallett KM: Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease. J Immunol. 2000, 164: 5015-5018.CrossRefPubMed

12.

Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005, 21: 263-265. 10.1093/bioinformatics/bth457.CrossRefPubMed

13.

Howson JM, Barratt BJ, Todd JA, Cordell HJ: Comparison of population- and family-based methods for genetic association analysis in the presence of interacting loci. Genet Epidemiol. 2005, 29: 51-67. 10.1002/gepi.20077.CrossRefPubMed

14.

Petrone A, Giorgi G, Galgani A, Alemanno I, Corsello SM, Signore A, Di Mario U, Nistico L, Cascino I, Buzzetti R: CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population. Thyroid. 2005, 15: 232-238. 10.1089/thy.2005.15.232.CrossRefPubMed

15.

Zhernakova A, Eerligh P, Barrera P, Weseloy JZ, Huizinga TW, Roep BO, Wijmenga C, Koeleman BP: CTLA4 is differentially associated with autoimmune diseases in the Dutch population. Hum Genet. 2005, 118: 58-66. 10.1007/s00439-005-0006-z.CrossRefPubMed

16.

Ban Y, Tozaki T, Taniyama M, Tomita M: Association of a CTLA-4 3' untranslated region (CT60) single nucleotide polymorphism with autoimmune thyroid disease in the Japanese population. Autoimmunity. 2005, 38: 151-153. 10.1080/08916930500050319.CrossRefPubMed

17.

Furugaki K, Shirasawa S, Ishikawa N, Ito K, Kubota S, Kuma K, Tamai H, Akamizu T, Hiratani H, Tanaka M, Sasazuki T: Association of the T-cell regulatory gene CTLA4 with Graves' disease and autoimmune thyroid disease in the Japanese. J Hum Genet. 2004, 49: 166-168. 10.1007/s10038-003-0120-5.CrossRefPubMed

18.

Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J: Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care. 2000, 23: 1516-1526.CrossRefPubMed

19.

Green A, Patterson CC: Trends in the incidence of childhood-onset diabetes in Europe 1989-1998. Diabetologia. 2001, 44 Suppl 3: B3-8. 10.1007/PL00002950.CrossRefPubMed

20.

Atabani SF, Thio CL, Divanovic S, Trompette A, Belkaid Y, Thomas DL, Karp CL: Association of CTLA4 polymorphism with regulatory T cell frequency. Eur J Immunol. 2005, 35: 2157-2162. 10.1002/eji.200526168.CrossRefPubMed

21.

Anjos SM, Shao W, Marchand L, Polychronakos C: Allelic effects on gene regulation at the autoimmunity-predisposing CTLA4 locus: a re-evaluation of the 3' +6230G>A polymorphism. Genes Immun. 2005, 6: 305-311. 10.1038/sj.gene.6364211.CrossRefPubMed

22.

Wagner DH, Hagman J, Linsley PS, Hodsdon W, Freed JH, Newell MK: Rescue of thymocytes from glucocorticoid-induced cell death mediated by CD28/CTLA-4 costimulatory interactions with B7-1/B7-2. J Exp Med. 1996, 184: 1631-1638. 10.1084/jem.184.5.1631.CrossRefPubMed

23.

Kuiper HM, Brouwer M, Linsley PS, van Lier RA: Activated T cells can induce high levels of CTLA-4 expression on B cells. J Immunol. 1995, 155: 1776-1783.PubMed

24.

Purohit S, Podolsky R, Collins C, Zheng W, Schatz D, Muir A, Hopkins D, Huang YH, She JX: Lack of correlation between the levels of soluble cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and the CT-60 genotypes. J Autoimmune Dis. 2005, 2: 8-10.1186/1740-2557-2-8.CrossRefPubMedPubMedCentral

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2350/8/3/prepub

Title: CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in northern Sweden
Authors: Sofia Mayans
Kurt Lackovic
Caroline Nyholm
Petter Lindgren
Karin Ruikka
Mats Eliasson
Corrado M Cilio
Dan Holmberg
Publication date: 01-12-2007
Publisher: BioMed Central
Published in: BMC Medical Genetics / Issue 1/2007
Electronic ISSN: 1471-2350
DOI: https://doi.org/10.1186/1471-2350-8-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in northern Sweden

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2007

CADASIL in Arabs: clinical and genetic findings

The candidate genes TAF5L, TCF7, PDCD1 , IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes

Detection of subtelomere imbalance using MLPA: validation, development of an analysis protocol, and application in a diagnostic centre

Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscle

Association of autism with polymorphisms in the paired-like homeodomain transcription factor 1 (PITX1) on chromosome 5q31: a candidate gene analysis

MRPS18CP2 alleles and DEFA3absence as putative chromosome 8p23.1 modifiers of hearing loss due to mtDNA mutation A1555G in the 12S rRNA gene